Recent Posts
Connect with:
Thursday / June 20.
HomemieyecareEssilorluxottica Anz Launches New Stellest Lenses To Slow Myopia

Essilorluxottica Anz Launches New Stellest Lenses To Slow Myopia

The much anticipated Essilor Stellest lenses have been launched in Australia/New Zealand to correct vision and slow down myopia progression in children.

Clinical trial results show that after two years, Essilor Stellest lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.1

Marco Caccini, General Manager Wholesale ANZ at EssilorLuxottica, said, “The Australian and New Zealand launch of Essilor Stellest lenses will no doubt provide new innovation for eye care professionals to help correct vision and fight myopia progression in children.

“With higher rates of childhood myopia, practices are going to be seeing more and more myopic young patients, with their parents seeking long term solutions. Correction of myopia with single vision lenses has no effect on slowing down the elongation of the eye.

“Given the risk of related ocular complications associated with high myopia later in life such as retinal detachment, glaucoma, PSC cataract and myopic macular degeneration, it is important to proactively slow down the progression of myopia in children.

“With more than thirty years of research and development experience in myopia, Essilor is proud to be at the forefront of myopia management with innovative solutions such as its Essilor Stellest lenses to help support better vision and eye health for children with myopia later in life. Essilor Stellest lenses now offer children the dual benefit of myopia correction and control, without any aesthetic compromise,” Mr Caccini said.

H.A.L.T. Technology.2

While there are other myopia control solutions, EssilorLuxottica has taken a step further to help control myopia by creating a unique technology tailored to the myopic eye: the H.A.L.T2 technology.

The constellation of 1,021 lenslets spread on 11 rings is designed to create for the first time a volume of signal that slows down the elongation of the eye. Based on scientific publications, EssilorLuxottica R&D experts concluded that a volume of signal has a stronger effect on the slowing down of myopia progression than a surface signal.

The aspherical lenslet design and their arrangement create this targeted effect of volume of non-focused light in front of the retina, following its shape.

In children, whose eyes are still developing, this volume of signal allows to keep the eye elongation process in check.

Creating a complete vision care system, Essilor Stellest lenses are complemented by a suite of advanced equipment from Essilor Instruments such as the Myopia Expert 700 and a comprehensive protocol to support eyecare professionals in the myopia care journey to elevate their myopia management practice. The Myopia Expert 700, distributed by Optimed will help eye-care professionals build a compelling myopia management journey from onset detection to monitoring and positioning these professionals as the reference in myopia.

Practitioner Support

Essilor Stellest lenses are specially designed for children and suitable for a variety of paediatric frames. In addition to customer partner launch events, EssilorLuxottica is also offering education and in-store assets and demonstration tools to support optometrists to introduce and explain the lens with patients and their parents.

Optimed technicians are also available for support with instruments. Essilor Stellest lenses provide a solid solution for the optometrist to recommend to children if they feel their myopia needs to be managed. It is EssilorLuxottica’s best solution to slow down myopia progression in children.

While current results are based on children from eight to 13 years old, Essilor Stellest lenses can be recommended to children as young as six and up to 16 years old, upon the decision of the optometrist.

Mr Caccini said, “EssilorLuxottica is deeply committed to tackling myopia to help make a much-needed impact on children’s lives everywhere. We have been working to advance research and innovation by bringing breakthrough solutions such as the Essilor Stellest lenses, to strengthen awareness and education to better equip ECPs and the public to manage myopia, and to help increase access to vision care and vision screenings.

“The launch forms part of our on-going mission to help people see more, be more and live life to its fullest, while continuing our role to be the best business partner for independent practices.”

1: Compared to single vision lenses, when worn 12 hours a day. Two-year prospective, controlled, randomised, double-masked clinical trial results on 54 myopic children wearing Stellest™ lenses compared to 50 myopic children wearing single vision lenses. Efficacy results based on 32 children who declared wearing Stellest™ lenses at least 12 hours per day every day. Bao J. et al. (2021). Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomised clinical trial. Invest. Ophthalmol. Vis. Sci.; 62(8):2888.
2: Highly Aspherical Lenslet Target